Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax
接受强化化疗和维奈托克治疗的初诊IDH突变型AML成年患者的预后
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02733-0
Croden, Jennifer; Jen, Wei-Ying; Marvin-Peek, Jennifer; Xiao, Lianchun; Bouligny, Ian M; Loghavi, Sanam; Borthakur, Gautam; Daver, Naval G; Abbas, Hussein A; Takahashi, Koichi; Sasaki, Koji; Pemmaraju, Naveen; Short, Nicholas J; Hammond, Danielle; Jabbour, Elias; Masarova, Lucia; Chien, Kelly S; Issa, Ghayas C; Montalban-Bravo, Guillermo; Yilmaz, Musa; Maiti, Abhishek; Alvarado-Valero, Yesid; Garcia-Manero, Guillermo; Ravandi, Farhad; Konopleva, Marina Y; Kantarjian, Hagop M; Kadia, Tapan M; DiNardo, Courtney D
